Filter your results
- 2
- 1
- 3
- 3
- 1
- 1
- 1
- 3
- 1
- 1
- 1
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
A novel virotherapy encoding human interleukin-7 improves ex vivo T lymphocyte functions in immunosuppressed patients with septic shock and critically ill COVID-19Frontiers in Immunology, 2022, 13, pp.939899. ⟨10.3389/fimmu.2022.939899⟩
Journal articles
inserm-04010224v1
|
||
|
IL-7 producing immunotherapy improves ex vivo T cell functions of immunosenescent patients, especially post hip fractureHuman Vaccines & Immunotherapeutics, 2023, 19 (2), ⟨10.1080/21645515.2023.2232247⟩
Journal articles
hal-04158445v1
|
||
|
Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trialHuman Vaccines & Immunotherapeutics, 2020, 16 (2), pp.388-399. ⟨10.1080/21645515.2019.1651141⟩
Journal articles
hal-02441611v1
|